Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7593018

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Net sales
18,197,000,000 JPY
76,034,000,000 JPY
18,453,000,000 JPY
Ordinary profit (loss)
4,332,000,000 JPY
17,542,000,000 JPY
4,660,000,000 JPY
Profit (loss) attributable to owners of parent
2,907,000,000 JPY
9,549,000,000 JPY
3,362,000,000 JPY
Comprehensive income
3,014,000,000 JPY
9,563,000,000 JPY
3,297,000,000 JPY
Net assets
137,853,000,000 JPY
138,325,000,000 JPY
135,699,000,000 JPY
Total assets
165,101,000,000 JPY
165,181,000,000 JPY
163,340,000,000 JPY
Basic earnings (loss) per share
76.91
251.43
87.78
Diluted earnings per share
Equity-to-asset ratio
0.831 xbrli:pure
0.834 xbrli:pure
0.831 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.